Treatments Provided by Dr. Mahesh Padsalge
Comprehensive long-term management of diabetes using glucose monitoring, medication, lifestyle modification and regular screening for complications.
Specialised management of Type 1 diabetes using insulin therapy, glucose monitoring, nutrition planning and regular assessment of treatment response.
Personalised treatment of Type 2 diabetes using oral medicines, injectable therapies, lifestyle changes and metabolic risk management.
Monitoring and treatment of diabetes developing during pregnancy to support appropriate blood glucose control for both mother and baby.
Individualised insulin treatment planning based on blood glucose patterns, lifestyle, meal timing and clinical requirements.
Use of continuous glucose monitoring technology to track glucose patterns throughout the day and improve treatment decisions.
Detailed interpretation of continuous glucose monitoring data to identify high, low and variable glucose patterns.
Assessment and ongoing guidance for suitable patients using insulin pump therapy for advanced diabetes management.
Personalised nutritional guidance designed to improve blood glucose control while supporting healthy and sustainable eating habits.
Education and guidance on medication adherence, glucose monitoring, exercise, diet and prevention of diabetes-related complications.
Evaluation and medical management of thyroid disorders including hypothyroidism and hyperthyroidism with appropriate laboratory monitoring.
Assessment and treatment of hormonal and metabolic disorders requiring specialist endocrinology care.
Medical evaluation of obesity and metabolic risk factors with personalised lifestyle and medical management where appropriate.
Assessment and treatment of abnormal cholesterol levels, especially in people with diabetes who have increased cardiovascular risk.
Regular evaluation for complications affecting the eyes, kidneys, nerves, feet and cardiovascular system in people living with diabetes.
Screening guidance and coordinated eye evaluation for patients with diabetes who may be at risk of diabetic retinal complications.